A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Medical College of Wisconsin
Case Comprehensive Cancer Center
BeiGene
Alliance for Clinical Trials in Oncology
University of Virginia
Memorial Sloan Kettering Cancer Center
Lumos Pharma
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
AbbVie
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Celgene
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
City of Hope Medical Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Baylor College of Medicine
Duke University
University of California, Davis
Northwestern University
Alliance for Clinical Trials in Oncology
Stanford University
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
Radiation Therapy Oncology Group